ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113452 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113452; 2) Community: the network communities that were significantly associated with the response to NSC 113452; 3) Molecule: the relationships between components within communities and NSC 113452; 4) MDR: the compounds that were significantly associated with the NSC 113452.

NSC Compound Enrichment Correlation
NSC 688228 Null 0.0237269271456697 0.02625778
NSC 6926 Null 0.0237269271456697 0.24375518
NSC 694509 Null 0.0237269271456697 -0.014655348
NSC 697535 Null 0.0237269271456697 0.40633567
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0237269271456697 0.19823784
NSC 709974 Null 0.0237269271456697 0.44474185
NSC 717468 Null 0.0237269271456697 0.047645703
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0237269271456697 -0.075002155
NSC 725098 Null 0.0237269271456697 0.34782249
NSC 726217 Combretastatin A4-analogue 0.0237269271456697 0.30455971
Total:109  Current:68    [First] [Prev] [Next] [Last]